Target intelligence / Profile preview

Epithelial cell transforming sequence 2 oncogene pseudogene (null)

Target
null
Molecular classification
Other (Pseudogene)
01

Overview

Epithelial cell transforming sequence 2 oncogene pseudogene (ENSG00000271701) is a genomic locus annotated as a pseudogene based on its high sequence similarity to the ECT2 (epithelial cell transforming sequence 2) oncogene, which encodes a guanine nucleotide exchange factor implicated in cell cycle regulation and oncogenesis. However, this particular locus contains disabling mutations or lacks necessary regulatory elements and thus does not produce a functional protein product. Pseudogenes such as this may occasionally be transcribed or serve as regulators of their parent gene through RNA-mediated mechanisms, but there is no evidence that ENSG00000271701 acts as a receptor, enzyme, transporter, or therapeutic target. This designation is commonly regarded as "incorrect" in the context of drug targeting, since it refers to a non-functional pseudogene rather than an active molecule or receptor relevant for therapeutic or diagnostic intervention[1][5].

Other names
ECT2PENSG00000271701Epithelial cell transforming sequence 2 pseudogene
02

Mechanism of action

None; pseudogenes do not produce active molecules subject to drug action.

03

Biological functions

None; pseudogenes generally do not encode functional proteins or have direct biological activities[1].
04

Disease associations

None established; pseudogenes may have regulatory effects in rare cases but are not direct disease mediators.
05

Safety considerations

None described; pseudogenes are not targeted therapeutically.
06

Interacting drugs

None; drugs target proteins, enzymes, receptors, or functional RNA, not pseudogenes.
07

Biomarkers

None established for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Epithelial cell transforming sequence 2 oncogene pseudogene (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epithelial cell transforming sequence 2 oncogene pseudogene (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call